Screener
BioSig Technologies, Inc.
STEXStreamex Corp. is a technology company specializing in digital financial infrastructure for the tokenization and lifecycle management of real-world assets (RWAs).
Earnings
Next report
Nov 12, 2026 (in 2 months)Revenue estimate$300.0K
EPS estimate-$0.03
Financials
Q2 2026Valuation & ratios
Segments
By segment
Competitors
By market cap
By revenue growth
TEC
Bio-Techne Corp.-0.4%
By net margin
TEC
Bio-Techne Corp.14.97%+4.2ppProfile
Streamex Corp. is a technology company specializing in digital financial infrastructure for the tokenization and lifecycle management of real-world assets (RWAs). The company provides an institutional-grade platform for the issuance, trading, and custody of digital tokens backed by tangible commodities, while maintaining a legacy biomedical technology business focused on advanced signal processing for cardiac electrophysiology.
Competitive position
Streamex is an early-stage entrant in the RWA tokenization market, pivoting from a legacy medical device background to focus on gold-backed digital assets.
GeographiesUnited States, Canada, Cayman Islands
Customer segmentsInstitutional investors, Accredited investors, Healthcare providers
Business modelInfrastructure-as-a-Service, Transaction-based fees, Licensing, Asset Management
SuppliersLBMA-accredited gold custodians, Blockchain network protocols, Special Purpose Vehicle (SPV) administrators, Software developers
CustomersQualified institutional buyers, Accredited retail investors, Cardiac surgery centers
CountryUnited States of America
Listed2014
Employees5.0
CEOKarl Henry McPhie
SectorHealthcare
IndustryMedical - Devices
Websitestreamex.com
FilingsSEC EDGAR
FAQ
- What is BioSig Technologies, Inc.'s market cap?
- BioSig Technologies, Inc. (STEX) has a market capitalization of $90.1M and trades on NASDAQ.
- What is BioSig Technologies, Inc.'s revenue and profitability?
- BioSig Technologies, Inc. generated $172.0K in trailing twelve-month revenue with a net loss of $500.8M, representing a net margin of -25825.0%. Gross margin stands at 80.1%. These figures are based on the Q2 2026 filing.
- Who are BioSig Technologies, Inc.'s competitors?
- BioSig Technologies, Inc.'s key competitors include Tradeweb Markets Inc., Bit Digital, Inc. Ordinary Shares, Greenlane Holdings, Inc. Class A Common Stock, and others. These companies compete in similar markets and product categories.
- Who does BioSig Technologies, Inc. partner with?
- BioSig Technologies, Inc.'s notable partners include Monetary Metals & Co., Mayo Foundation for Medical Education and Research, Needham & Company, LLC, and others.
- What subsidiaries does BioSig Technologies, Inc. have?
- BioSig Technologies, Inc.'s subsidiaries include Streamex Exchange Corporation, ViralClear Pharmaceuticals, Inc., BioSig AI Sciences, Inc..
- Where is BioSig Technologies, Inc. headquartered?
- BioSig Technologies, Inc. is headquartered in United States of America and employs approximately 5 people. It has been publicly traded since 2014.
